PCM
ACH

Prelude Capital Management’s Accendra Health ACH Stock Holding History

Prelude Capital Management’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,503
Closed -$93.6K – 1484
2025
Q3 		$93.6K Buy
+19,503
New +$124K 0.01% 1061
2025
Q2 		– Sell
-15,146
Closed -$137K – 1254
2025
Q1 		$137K Buy
+15,146
New +$160K 0.01% 1003
2024
Q3 		– Sell
-13,316
Closed -$180K – 1483
2024
Q2 		$180K Buy
+13,316
New +$273K 0.01% 1028
2019
Q4 		– Sell
-216
Closed -$1K – 2156
2019
Q3 		$1K Sell
216
-26
-11% -$117 ﹤0.01% 1642
2019
Q2 		$1K Sell
242
-10
-4% -$34 ﹤0.01% 1595
2019
Q1 		$1K Sell
252
-9,240
-97% -$58.4K ﹤0.01% 1706
2018
Q4 		$60K Buy
9,492
+8,330
+717% +$86.5K ﹤0.01% 1074
2018
Q3 		$19K Buy
1,162
+1,006
+645% +$17.1K ﹤0.01% 1316
2018
Q2 		$3K Sell
156
-65
-29% -$1.05K ﹤0.01% 1589
2018
Q1 		$3K Buy
+221
New +$3.94K ﹤0.01% 1440
2017
Q4 		– Sell
-16,200
Closed -$473K – 1607
2017
Q3 		$473K Buy
16,200
+10,500
+184% +$310K 0.04% 395
2017
Q2 		$183K Buy
5,700
+759
+15% +$24.9K 0.02% 601
2017
Q1 		$171K Sell
4,941
-8,567
-63% -$306K 0.02% 618
2016
Q4 		$477K Sell
13,508
-2,777
-17% -$93.8K 0.06% 324
2016
Q3 		$566K Buy
16,285
+11,723
+257% +$410K 0.06% 286
2016
Q2 		$171K Buy
4,562
+3,010
+194% +$113K 0.02% 543
2016
Q1 		$63K Buy
+1,552
New +$57.8K 0.01% 909
2015
Q4 		– Sell
-2,143
Closed -$68K – 1623
2015
Q3 		$68K Buy
2,143
+1,593
+290% +$54.2K 0.01% 959
2015
Q2 		$19K Sell
550
-948
-63% -$31.9K ﹤0.01% 1392
2015
Q1 		$51K Buy
+1,498
New +$52.2K 0.01% 1273
2014
Q4 		– Sell
-1,847
Closed -$60K – 2091
2014
Q3 		$60K Buy
+1,847
New +$62.9K 0.01% 1325

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Prelude Capital Management's ACH Position: Q4 2025 in Review

Prelude Capital Management sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 19,503 shares — an estimated $93.6K sold.

Prelude Capital Management first reported a position in ACH in Q3 2014 and held it in 21 quarters. The position peaked at $566K in Q3 2016. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

  • Prelude Capital Management reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 19,503 Accendra Health shares in Q4 2025, an estimated $93.6K.
  • Prelude Capital Management first reported a position in Accendra Health in Q3 2014 and held it in 21 quarters.
  • Prelude Capital Management's Accendra Health position peaked at $566K in Q3 2016.
  • 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.